TREATMENT OF TERMINAL CANCER PAIN IN FINLAND - A 2ND LOOK

被引:21
作者
VAINIO, A
机构
[1] Department of Anesthesia, Helsinki University Central Hospital, Helsinki
关键词
ANALGESIC THERAPY; CANCER PAIN TREATMENT; MEDICAL PRACTICE; PALLIATIVE CARE;
D O I
10.1111/j.1399-6576.1992.tb03429.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
A questionnaire concerning the treatment of cancer pain was sent to 10% and 5% random samples of Finnish physicians in 1985 and in 1990, respectively. The physicians were asked about their current practice in the treatment of pain in their cancer patients, and about their main clinical problems when treating pain. Three simulated patient cases were presented, and the adequacy of the suggestions for therapy was evaluated. The results indicated that Finnish physicians had adopted a more rational and effective analgesic therapy during the 5-year period. Treatment suggestions for the simulated patient cases had improved both in terms of daily doses of analgesics and of dose intervals, but the doses of opioids were still below those commonly used in chronic cancer pain. The clinical difficulties experienced by the physicians had changed: instead of being frustrated by the inefficacy of their treatment as in 1985, physicians were now working on the problem of finding a suitable preparation and dosage. The results suggest that the voluntary activity of patient organizations, a few pain clinics, and a few clinicians interested in pain treatment have been able to improve the practising physicians' theoretical knowledge in 5 years. In contrast to the improvement in the knowledge and skills, changing attitudes takes much longer. As many as 39% of physicians who see cancer patients at least occasionally, reported that they still had not acquired the prescription sheets necessary to prescribe opioids to outpatients.
引用
收藏
页码:89 / 95
页数:7
相关论文
共 27 条
[1]  
BEAVER WT, 1978, J PHARMACOL EXP THER, V207, P92
[2]  
BONICA JJ, 1986, SEMIN ANESTH PERIO M, V5, P82
[3]  
Bruera E, 1990, J Pain Symptom Manage, V5, P1, DOI 10.1016/S0885-3924(05)80002-8
[4]  
DORREPAAL KL, 1989, CANCER, V63, P593, DOI 10.1002/1097-0142(19890201)63:3<593::AID-CNCR2820630332>3.0.CO
[5]  
2-5
[6]  
Foley K., 1979, CURRENT NEUROLOGY, P279
[7]   FACTORS INFLUENCING DRUG PRESCRIBING - INQUIRY INTO RESEARCH STRATEGY [J].
HEMMINKI, E .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1976, 10 (06) :321-329
[8]  
HEMMINKI E, 1988, PSYCHOACTIVE DRUGS I, P22
[9]  
JAFFE JH, 1985, GOODMAN GILMANS PHAR, P521
[10]   MORPHINE AND OXYCODONE HYDROCHLORIDE IN THE MANAGEMENT OF CANCER PAIN [J].
KALSO, E ;
VAINIO, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (05) :639-646